Brandywine Pharmaceuticals, LLC recalls

2 recalls.

• Theophylline Extended-Release Tablets recall (Brandywine Pharmaceuticals, LLC)
  DrugClass IIReported November 4, 2026 · CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
• Theophylline Extended-Release Tablets recall (Brandywine Pharmaceuticals, LLC)
  DrugClass IIReported November 4, 2026 · CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory